Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2005
03/31/2005WO2005027978A2 Albumin-binding derivatives of therapeutic peptides
03/31/2005WO2005027977A2 Diclofenac compositions for the treatment of skin disorders
03/31/2005WO2005027966A2 Antibodies with altered effector functions
03/31/2005WO2005027960A1 Liquid human growth hormone formulation containing polyethylene glycol
03/31/2005WO2005027957A1 Multiple-arm peptide compounds, methods of manufacture and use in therapy
03/31/2005WO2005027954A2 Sincalide formulations
03/31/2005WO2005027941A1 Skin preparation for external use
03/31/2005WO2005027939A1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
03/31/2005WO2005027911A1 Hormone concentrate pharmaceutical compositon
03/31/2005WO2005027895A2 Thyroid hormone analogs and methods of use in angiogenesis
03/31/2005WO2005027873A2 Therapeutic aminoglycoside-containing hydrogel nanoparticles
03/31/2005WO2005027871A2 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof
03/31/2005WO2005027859A2 Patch
03/31/2005WO2005027852A2 Compositions of polyacids and polyethers and methods for their use in reducing pain
03/31/2005WO2005027841A2 Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease
03/31/2005WO2005027836A2 Immunogen
03/31/2005WO2005027828A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
03/31/2005WO2005016949A3 Sialic acid derivatives
03/31/2005WO2005012495A3 Methods for expression and purification of immunotoxins
03/31/2005WO2005007197A3 Conjugated biological molecules and their preparation
03/31/2005WO2005002482A8 Transdermal hormone delivery system: compositions and methods
03/31/2005WO2004092394A3 Fluid planar lipid layer-based membrane-anchored ligand system with specific binding pair members and methods of use thereof
03/31/2005WO2004091553A3 Film forming polymers, methods of use, and devices and applications thereof
03/31/2005WO2004080383A3 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
03/31/2005WO2004076369A3 Antimicrobial active borosilicate glass
03/31/2005WO2004069187A3 Drug formulation and delivery using crystalline methylated cyclodextrins
03/31/2005WO2004064595A3 Multivalent constructs for therapeutic and diagnostic applications
03/31/2005WO2004032900A8 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
03/31/2005WO2004006959A8 Liquid dosage compositions of stable nanoparticulate active agents
03/31/2005WO2003072754A3 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use
03/31/2005WO2003070909A3 Microparticles with adsorbed polypeptide-containing molecules
03/31/2005US20050071003 Poly(vinyl alcohol) hydrogel
03/31/2005US20050070670 Novel adjuvants and copolymer compositions
03/31/2005US20050070610 Dermal compositions containing coenzyme q as the active ingredient
03/31/2005US20050070502 Orally administering a starch in granulated form having a reduced surface available for enzymatic degradation, which releases reducing sugars at a controlled rate; for nocturnal hypoglycemia in diabetes patients, endurance athletes
03/31/2005US20050070500 Method of modulating release of saccharides and uses thereof
03/31/2005US20050070497 Diabetes, insulin resistance and obesity for example
03/31/2005US20050070491 Immunostimulatory nucleic acid molecules
03/31/2005US20050070486 Microspherules containing a pleuromutilin derivative
03/31/2005US20050070484 Treating retinopathy both of diabetes and prematurity, or tumor growth
03/31/2005US20050070481 By adding an antioxidant and/or a chelating agent in the same aqueous solution; reduced coenzyme Q10, vitamin C and ethylenediaminetetracetic acid for example
03/31/2005US20050070479 Oligo or polyalkylene glycol-coupled thrombin inhibitors
03/31/2005US20050070477 Lung surfactant polypeptide, and at least one inhibitor of a mediator of tissue destruction; for example protease inhibitors; treating inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease
03/31/2005US20050070470 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
03/31/2005US20050070466 Diagnostic imaging agents; targeting vectors which bind to integrin receptors; bicyclic arginine-glycine-aspartic acid derivatives; stablility; reduced background interference
03/31/2005US20050070465 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon
03/31/2005US20050070462 Contacting with cationic polymer
03/31/2005US20050069961 Isotope-coded affinity tag
03/31/2005US20050069947 Antibodies specific for nanotubes and related methods and compositions
03/31/2005US20050069889 Novel metastasis suppressor gene on human chromosome 8
03/31/2005US20050069590 Stable suspensions for medicinal dosages
03/31/2005US20050069588 Preparation containing polydimethylsiloxane for nail, cartilage,bone, joint,muscle and tendon disorders
03/31/2005US20050069586 Mixture with stabilization lubricant and excipients
03/31/2005US20050069583 Solid, digestable mixture of alginate, (bi)carbonate and polyol; gastrointestinal disorders
03/31/2005US20050069581 Fish gelatin hard capsule and its preparation method
03/31/2005US20050069580 Compositions containing both sedative and non-sedative antihistamines and sleep aids
03/31/2005US20050069578 Reconstitution medium for protein and peptide formulations
03/31/2005US20050069577 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
03/31/2005US20050069575 Water soluble sheet composition
03/31/2005US20050069563 Method for treating herpes simplex virus and fungal pimples with antifungal medication
03/31/2005US20050069551 cytotoxic compound, such as 3,5-bis(2-fluorobenzylidene)piperidin-4-one acetate bonded to protein; antitumor agents; anticarcinogenic agents; restenosis; antiarthritic agents;antiinflammatory agents
03/31/2005US20050069550 Dendritic encapsulation of active agents
03/31/2005US20050069543 Antibody mixture; immunosuppressant ; antitumor agents
03/31/2005US20050069542 Antibodies that specifically bind to GMAD
03/31/2005US20050069533 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof
03/31/2005US20050069513 Amphiphilic compounds for pharmaceutical or cosmetic use
03/31/2005DE10341317A1 Mittel zur transdermalen Applikation Means for transdermal administration
03/31/2005DE10341043A1 Neue oral zu applizierende Darreichungsform für New dosage form for oral administration for 3-[(2-{[4-Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester und dessen Salze and its salts
03/31/2005DE10338464A1 Using RNA-peptide conjugates for specific gene regulation, useful e.g. for treatment and diagnosis of tumors, provides high transfection efficiency in both isolated cells and organisms
03/31/2005CA2805552A1 Thyroid hormone analogs and methods of use in angiogenesis
03/31/2005CA2799282A1 Multi-arm polymer prodrugs
03/31/2005CA2540172A1 Liquid human growth hormone formulation containing polyethylene glycol
03/31/2005CA2539799A1 5-aminosalicylic acid solid preparation improved in discoloration and method of storing the same
03/31/2005CA2539288A1 Thyroid hormone analogs and methods of use
03/31/2005CA2539270A1 Immunogen
03/31/2005CA2539253A1 Albumin-binding derivatives of therapeutic peptides
03/31/2005CA2537080A1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
03/31/2005CA2534959A1 Antibodies with altered effector functions
03/30/2005EP1518937A1 Increasing the concentration of a nucleic acid molecule
03/30/2005EP1518900A2 Liquid compositions comprising an oxyalkylated polyglycerolester
03/30/2005EP1518552A1 Fish gelatin hard capsule and its preparation method
03/30/2005EP1518550A2 Bioadhesive drug delivery systems comprising poly(fumaric-co-sebacic acid)
03/30/2005EP1518517A2 Drug-delivery endovascular stent and method for treating restenosis
03/30/2005EP1517981A2 Stabilization of granules
03/30/2005EP1517722A1 Transdermal drug delivery devices having coated microprotrusions
03/30/2005EP1517710A1 Pegylated factor vii glycoforms
03/30/2005EP1517709A1 Transdermal drug delivery system
03/30/2005EP1517697A1 Acidic insulin preparations with improved stability
03/30/2005EP1517682A1 Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
03/30/2005EP1517677A1 Popping oral administration form
03/30/2005EP1517676A1 Oral dosage forms comprising fenofibrate
03/30/2005EP1517673A1 Nasal composition comprising a mucopolysaccharide and propylene glycol
03/30/2005EP1517672A1 Compositions and methods for amelioration of human female sexual dysfunction
03/30/2005EP1517671A2 Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton
03/30/2005EP1450770B1 Pharmaceutical composition comprising a 5ht1 receptor agonist
03/30/2005EP1436007B1 Compounds for use as surfactants
03/30/2005EP1307182B1 Pharmaceutical composition for transdermal delivery of befloxatone
03/30/2005EP1282448B1 Heterobifunctional cross-linking agent conjugate substituted by an immunomodulator and cell recognition unit
03/30/2005EP1253150B1 Polymeric micellar structure
03/30/2005EP1250133B1 Ophthalmic anti-allergy compositions suitable for use with contact lenses
1 ... 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 ... 1712